CN1207033C - 一种治疗风热感冒的中药组合物及其制备方法 - Google Patents
一种治疗风热感冒的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN1207033C CN1207033C CNB031001882A CN03100188A CN1207033C CN 1207033 C CN1207033 C CN 1207033C CN B031001882 A CNB031001882 A CN B031001882A CN 03100188 A CN03100188 A CN 03100188A CN 1207033 C CN1207033 C CN 1207033C
- Authority
- CN
- China
- Prior art keywords
- weight portion
- radix
- pharmaceutical composition
- herba
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims abstract description 6
- 239000000203 mixture Substances 0.000 title abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 238000004821 distillation Methods 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 19
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 241000207929 Scutellaria Species 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 88
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 241000628997 Flos Species 0.000 claims description 23
- 239000000796 flavoring agent Substances 0.000 claims description 21
- 235000019634 flavors Nutrition 0.000 claims description 21
- 210000000582 semen Anatomy 0.000 claims description 20
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 20
- 239000008194 pharmaceutical composition Substances 0.000 claims description 18
- 239000012141 concentrate Substances 0.000 claims description 15
- 239000008187 granular material Substances 0.000 claims description 13
- 238000002347 injection Methods 0.000 claims description 11
- 239000007924 injection Substances 0.000 claims description 11
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 11
- 238000004321 preservation Methods 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 10
- 230000006837 decompression Effects 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000004064 recycling Methods 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- -1 correctives Substances 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 241000245240 Lonicera Species 0.000 claims description 2
- 230000002421 anti-septic effect Effects 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 239000002270 dispersing agent Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 235000008216 herbs Nutrition 0.000 abstract 3
- 201000009240 nasopharyngitis Diseases 0.000 abstract 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000001405 Artemisia annua Nutrition 0.000 abstract 1
- 240000000011 Artemisia annua Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 235000006751 Platycodon Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 1
- 244000018633 Prunus armeniaca Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229930189914 platycodon Natural products 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 description 29
- 239000006188 syrup Substances 0.000 description 29
- 206010011224 Cough Diseases 0.000 description 22
- 241000699670 Mus sp. Species 0.000 description 22
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 18
- 229910052709 silver Inorganic materials 0.000 description 18
- 239000004332 silver Substances 0.000 description 18
- 230000036760 body temperature Effects 0.000 description 17
- 241000699666 Mus <mouse, genus> Species 0.000 description 13
- 235000008504 concentrate Nutrition 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 241000700159 Rattus Species 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 206010022000 influenza Diseases 0.000 description 10
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 241000700199 Cavia porcellus Species 0.000 description 6
- 230000000954 anitussive effect Effects 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 229960005486 vaccine Drugs 0.000 description 6
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 230000001754 anti-pyretic effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 241000193998 Streptococcus pneumoniae Species 0.000 description 4
- 208000037386 Typhoid Diseases 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 201000008297 typhoid fever Diseases 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000002155 anti-virotic effect Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 239000011533 mixed conductor Substances 0.000 description 3
- 231100000028 nontoxic concentration Toxicity 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000011951 anti-virus test Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000007541 cellular toxicity Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000252870 H3N2 subtype Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000134304 Influenza A virus H3N2 Species 0.000 description 1
- 241001500351 Influenzavirus A Species 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 241001662443 Phemeranthus parviflorus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 241001627955 Tetraodon lineatus Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 231100001134 median toxic concentration Toxicity 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02G—INSTALLATION OF ELECTRIC CABLES OR LINES, OR OF COMBINED OPTICAL AND ELECTRIC CABLES OR LINES
- H02G11/00—Arrangements of electric cables or lines between relatively-movable parts
- H02G11/02—Arrangements of electric cables or lines between relatively-movable parts using take-up reel or drum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65H—HANDLING THIN OR FILAMENTARY MATERIAL, e.g. SHEETS, WEBS, CABLES
- B65H75/00—Storing webs, tapes, or filamentary material, e.g. on reels
- B65H75/02—Cores, formers, supports, or holders for coiled, wound, or folded material, e.g. reels, spindles, bobbins, cop tubes, cans, mandrels or chucks
- B65H75/34—Cores, formers, supports, or holders for coiled, wound, or folded material, e.g. reels, spindles, bobbins, cop tubes, cans, mandrels or chucks specially adapted or mounted for storing and repeatedly paying-out and re-storing lengths of material provided for particular purposes, e.g. anchored hoses, power cables
- B65H75/38—Cores, formers, supports, or holders for coiled, wound, or folded material, e.g. reels, spindles, bobbins, cop tubes, cans, mandrels or chucks specially adapted or mounted for storing and repeatedly paying-out and re-storing lengths of material provided for particular purposes, e.g. anchored hoses, power cables involving the use of a core or former internal to, and supporting, a stored package of material
- B65H75/40—Cores, formers, supports, or holders for coiled, wound, or folded material, e.g. reels, spindles, bobbins, cop tubes, cans, mandrels or chucks specially adapted or mounted for storing and repeatedly paying-out and re-storing lengths of material provided for particular purposes, e.g. anchored hoses, power cables involving the use of a core or former internal to, and supporting, a stored package of material mobile or transportable
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65H—HANDLING THIN OR FILAMENTARY MATERIAL, e.g. SHEETS, WEBS, CABLES
- B65H75/00—Storing webs, tapes, or filamentary material, e.g. on reels
- B65H75/02—Cores, formers, supports, or holders for coiled, wound, or folded material, e.g. reels, spindles, bobbins, cop tubes, cans, mandrels or chucks
- B65H75/34—Cores, formers, supports, or holders for coiled, wound, or folded material, e.g. reels, spindles, bobbins, cop tubes, cans, mandrels or chucks specially adapted or mounted for storing and repeatedly paying-out and re-storing lengths of material provided for particular purposes, e.g. anchored hoses, power cables
- B65H75/38—Cores, formers, supports, or holders for coiled, wound, or folded material, e.g. reels, spindles, bobbins, cop tubes, cans, mandrels or chucks specially adapted or mounted for storing and repeatedly paying-out and re-storing lengths of material provided for particular purposes, e.g. anchored hoses, power cables involving the use of a core or former internal to, and supporting, a stored package of material
- B65H75/44—Constructional details
- B65H75/4457—Arrangements of the frame or housing
- B65H75/4468—Tubular frame
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65H—HANDLING THIN OR FILAMENTARY MATERIAL, e.g. SHEETS, WEBS, CABLES
- B65H2301/00—Handling processes for sheets or webs
- B65H2301/50—Auxiliary process performed during handling process
- B65H2301/51—Modifying a characteristic of handled material
- B65H2301/514—Modifying physical properties
- B65H2301/5144—Cooling
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01B—CABLES; CONDUCTORS; INSULATORS; SELECTION OF MATERIALS FOR THEIR CONDUCTIVE, INSULATING OR DIELECTRIC PROPERTIES
- H01B7/00—Insulated conductors or cables characterised by their form
- H01B7/42—Insulated conductors or cables characterised by their form with arrangements for heat dissipation or conduction
- H01B7/421—Insulated conductors or cables characterised by their form with arrangements for heat dissipation or conduction for heat dissipation
- H01B7/426—Insulated conductors or cables characterised by their form with arrangements for heat dissipation or conduction for heat dissipation using cooling fins, ribs
Landscapes
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Storing, Repeated Paying-Out, And Re-Storing Of Elongated Articles (AREA)
Abstract
Description
Claims (8)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031001882A CN1207033C (zh) | 2003-01-09 | 2003-01-09 | 一种治疗风热感冒的中药组合物及其制备方法 |
PCT/IB2003/004656 WO2004062054A1 (en) | 2003-01-07 | 2003-10-22 | Electric cable storage device |
AU2003278405A AU2003278405A1 (en) | 2003-01-07 | 2003-10-22 | Electric cable storage device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031001882A CN1207033C (zh) | 2003-01-09 | 2003-01-09 | 一种治疗风热感冒的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1425449A CN1425449A (zh) | 2003-06-25 |
CN1207033C true CN1207033C (zh) | 2005-06-22 |
Family
ID=4789791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031001882A Expired - Lifetime CN1207033C (zh) | 2003-01-07 | 2003-01-09 | 一种治疗风热感冒的中药组合物及其制备方法 |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1207033C (zh) |
AU (1) | AU2003278405A1 (zh) |
WO (1) | WO2004062054A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105770074A (zh) * | 2016-04-20 | 2016-07-20 | 山东明仁福瑞达制药股份有限公司 | 一种治疗风热感冒的中药组合物及其制备方法 |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE202004017665U1 (de) * | 2004-11-15 | 2005-02-03 | Heinrich Kopp Gmbh | Vorrichtung zum Aufwickeln eines Kabels oder eines band- bzw. schlauchförmigen Gegenstands |
CN100409862C (zh) * | 2005-03-01 | 2008-08-13 | 重庆大易科技投资有限公司 | 一种治疗上呼吸道感染的中药组合物及其制备方法 |
CN1985921B (zh) * | 2005-12-20 | 2011-04-06 | 广州王老吉药业股份有限公司 | 一种治疗感冒的中药组合物及其制备方法 |
CN100348231C (zh) * | 2006-03-06 | 2007-11-14 | 成都厚发科技开发有限公司 | 具有抗外感高热作用的药物组合物及其制备方法 |
WO2007112477A1 (en) * | 2006-04-03 | 2007-10-11 | Tks Electrics Pty Ltd | Cable storage device |
CN101152202B (zh) * | 2007-09-29 | 2010-11-24 | 中国药科大学 | 治疗呼吸***疾病的药物组合物及其制备方法 |
CN102188533A (zh) * | 2010-03-03 | 2011-09-21 | 鲁南厚普制药有限公司 | 一种治疗风热感冒的口服液体制剂及其制备方法 |
AT511018B1 (de) * | 2011-01-18 | 2013-04-15 | Feller Gmbh | Kabeltrommelkabel |
CN103083584A (zh) * | 2011-11-04 | 2013-05-08 | 陈良鉴 | 一种治疗流行性感冒的中药 |
FR3023075A1 (fr) * | 2014-06-27 | 2016-01-01 | Commissariat Energie Atomique | Fiche de raccordement electrique |
FR3023055B1 (fr) | 2014-06-27 | 2018-02-23 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Dispositif enrouleur de cable electrique |
CN104367941A (zh) * | 2014-11-03 | 2015-02-25 | 山东瑞康生命科技有限公司 | 一种治疗登革热的中药制剂的制备方法 |
CN105250920A (zh) * | 2015-11-10 | 2016-01-20 | 北京市祖国红医疗科技中心(有限合伙) | 治疗雾霾所引起呼吸道疾病的中药、其制备方法及应用 |
CN106334040A (zh) * | 2016-08-31 | 2017-01-18 | 安徽省润生医药股份有限公司 | 治疗风热感冒的药物组合物、其制备方法及制剂 |
CN111228357A (zh) * | 2018-11-28 | 2020-06-05 | 鲁南制药集团股份有限公司 | 一种柴银微丸制剂及其制备方法 |
CN111297969A (zh) * | 2020-03-25 | 2020-06-19 | 鲁南制药集团股份有限公司 | 柴银制剂在制备抗冠状病毒药物中的应用及其制备方法 |
CN113521210B (zh) * | 2020-04-17 | 2024-04-16 | 天士力医药集团股份有限公司 | 一种含有香薷的中药组合物 |
CN111450166A (zh) * | 2020-05-14 | 2020-07-28 | 鲁南制药集团股份有限公司 | 柴银制剂在抗肠道病毒中的新用途 |
CN112843184A (zh) * | 2020-12-10 | 2021-05-28 | 石门县中医医院 | 一种治疗风热感冒的药物组合物及其应用 |
CN114917298B (zh) * | 2022-05-07 | 2023-10-20 | 森隆药业有限公司 | 一种治疗肺炎的药物组合物及其制备方法 |
CN115227770A (zh) * | 2022-07-23 | 2022-10-25 | 安阳市中医院 | 一种治疗小儿外感发热的中药组合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE840867C (de) * | 1950-01-03 | 1952-06-05 | Siemens Ag | Elektrisches Kabel mit nichtmetallischem Schutzmantel |
CH278388A (de) * | 1950-04-12 | 1951-10-15 | Zanoni Fritz | Vorrichtung an elektrischen Kabeln. |
DE1765452U (de) * | 1956-05-31 | 1958-04-24 | Siemens Ag | Elektrisches kabel mit einem im strang-spritzverfahren hergestellten aussenmantel aus kunststoff. |
DE3401026A1 (de) * | 1984-01-13 | 1985-07-18 | Hugo Brennenstuhl GmbH & Co KG, 7400 Tübingen | Tragbare kabeltrommel |
IT234264Y1 (it) * | 1994-12-01 | 2000-03-09 | Cavis Srl | Struttura di guaina protettiva continua per il rivestimento di un fascio di cavi elettrici |
DE19804715A1 (de) * | 1998-02-06 | 1999-08-12 | Murrplastik Systemtechnik Gmbh | Kabel |
JP2001031332A (ja) * | 1999-07-23 | 2001-02-06 | Mitsubishi Cable Ind Ltd | 給電用ドラム |
JP2001357728A (ja) * | 2000-06-13 | 2001-12-26 | Sumitomo Wiring Syst Ltd | 電線およびその作製方法 |
JP2002193555A (ja) * | 2000-12-27 | 2002-07-10 | Fujikura Ltd | 移動機器用の給電ケーブルリール装置およびケーブルリール |
-
2003
- 2003-01-09 CN CNB031001882A patent/CN1207033C/zh not_active Expired - Lifetime
- 2003-10-22 WO PCT/IB2003/004656 patent/WO2004062054A1/en not_active Application Discontinuation
- 2003-10-22 AU AU2003278405A patent/AU2003278405A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105770074A (zh) * | 2016-04-20 | 2016-07-20 | 山东明仁福瑞达制药股份有限公司 | 一种治疗风热感冒的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
AU2003278405A1 (en) | 2004-07-29 |
WO2004062054A1 (en) | 2004-07-22 |
CN1425449A (zh) | 2003-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1207033C (zh) | 一种治疗风热感冒的中药组合物及其制备方法 | |
CN101040915A (zh) | 一种双黄连注射液的制备方法及其成分检测方法 | |
CN1248725C (zh) | 一种治疗急、慢性咽喉炎、扁桃体炎的复方中药制剂 | |
CN1772079A (zh) | 一种治疗上呼吸道感染的药物及其制备方法 | |
CN1943675A (zh) | 清热化痰、止咳平喘的藏药药物组合物及其制备方法 | |
CN1857362A (zh) | 金感康药物制剂及其制备方法 | |
CN101053600A (zh) | 治疗感冒的药物组合物及其制备方法和用途 | |
CN1323668C (zh) | 一种药物组合物及其制药用途 | |
CN1903254A (zh) | 治疗风热感冒的复方药物及其制备方法 | |
CN1606979A (zh) | 黄芩素作为解热、镇痛、抗炎、抗菌、抗病毒剂的作用 | |
CN100337658C (zh) | 治疗感冒风热症的中药组合物及其制备方法 | |
CN100339101C (zh) | 藿香正气滴丸的制备方法及其用途 | |
CN1056298C (zh) | 一种治疗软组织损伤的外用药及其生产方法 | |
CN1814221A (zh) | 一种治疗***的中药组合物及其制备方法 | |
CN1211094C (zh) | 一种治疗肺结核病的药物 | |
CN1323681C (zh) | 一种治疗上呼吸道感染的复方制剂及其在制药中的应用 | |
CN1947756A (zh) | 七味解毒活血药物组合配方及其制备工艺和用途 | |
CN1742845A (zh) | 一种治疗呼吸***疾患的中药组合物及其制备方法 | |
CN1589892A (zh) | 一种治疗急、慢性咽炎的药物组合物及其制备方法 | |
CN1287811C (zh) | 一种治疗呼吸道病毒感染性疾病的清肺制剂 | |
CN1813916A (zh) | 一种用于治疗感冒的中药复方制剂及其制备工艺 | |
CN1220515C (zh) | 一种治疗咽喉疾病的药物 | |
CN1903343A (zh) | 一种治疗胆道结石的药物组合物及其制备方法和用途 | |
CN1602945A (zh) | 通窍鼻炎软胶囊及其制备工艺 | |
CN1634413A (zh) | 一种勒马回注射制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: LUNAN PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME OR ADDRESS: LUNAN PHARMACY CO. LTD. |
|
CP03 | Change of name, title or address |
Address after: 276005 No. 209 Hongqi Road, Shandong, Linyi Patentee after: LUNAN PHARMACEUTICAL Group Corp. Address before: 276003 No. 107, No. 1, Linxi, Shandong, Linyi Patentee before: Lunan Pharmaceutical Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: LUNAN HOPE PHARMACEUTICAL Co.,Ltd. Assignor: LUNAN PHARMACEUTICAL Group Corp. Contract record no.: 2010370000515 Denomination of invention: Chinese medicine composition for treating wind-heat type common cold Granted publication date: 20050622 License type: Exclusive License Open date: 20030625 Record date: 20100909 |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: LUNAN HOPE PHARMACEUTICAL Co.,Ltd. Assignor: LUNAN PHARMACEUTICAL Group Corp. Contract record no.: 2010370000515 Date of cancellation: 20131016 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20030625 Assignee: LUNAN HOPE PHARMACEUTICAL Co.,Ltd. Assignor: LUNAN PHARMACEUTICAL Group Corp. Contract record no.: 2013370000262 Denomination of invention: Chinese medicine composition for treating wind-heat type common cold Granted publication date: 20050622 License type: Exclusive License Record date: 20131210 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161230 Address after: 276005 Hongqi Road, Shandong, Linyi, No. 209 Patentee after: LUNAN HOPE PHARMACEUTICAL Co.,Ltd. Address before: 276005 Hongqi Road, Shandong, Linyi, No. 209 Patentee before: LUNAN PHARMACEUTICAL Group Corp. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20050622 |